Lipoprotein(a) Management: Pharmacological and Apheretic Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|10|957-968

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.10, 2017-05, pp. : 957-968

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein(a): Medical Treatment Options for an Elusive Molecule

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-01 ,pp. : 871-876

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)?

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1562-1570

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

By Abudy Anat   Juven-Wetzler Alzbeta   Zohar Joseph  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 585-596

Adis International

Access to resources Recommend Favorite

Management of Spondyloarthropathy: New Pharmacological Treatment Options

By Lee R.Z.   Veale D.J.  

Drugs, Vol. 62, Iss. 16, 2002-01 ,pp. : 2349-2359

Adis International

Access to resources Recommend Favorite

Pharmacological Cardioversion of Atrial Fibrillation: Current Management and Treatment Options

By Boriani Giuseppe   Diemberger Igor   Biffi Mauro   Martignani Cristian   Branzi Angelo  

Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. : 2741-2762

Adis International

Access to resources Recommend Favorite